156 related articles for article (PubMed ID: 2580959)
1. Antigenic heterogeneity of human anaplastic gliomas and glioma-derived cell lines defined by monoclonal antibodies.
Wikstrand CJ; Grahmann FC; McComb RD; Bigner DD
J Neuropathol Exp Neurol; 1985 May; 44(3):229-41. PubMed ID: 2580959
[TBL] [Abstract][Full Text] [Related]
2. Five new epitope-defined monoclonal antibodies reactive with GM2 and human glioma and medulloblastoma cell lines.
Vrionis FD; Wikstrand CJ; Fredman P; Månsson JE; Svennerholm L; Bigner DD
Cancer Res; 1989 Dec; 49(23):6645-51. PubMed ID: 2479468
[TBL] [Abstract][Full Text] [Related]
3. Antigenic heterogeneity of human colorectal cancer cell lines analyzed by a panel of monoclonal antibodies. I. Heterogeneous expression of Ia-like and HLA-like antigenic determinants.
MacLean GD; Seehafer J; Shaw AR; Kieran MW; Longenecker BM
J Natl Cancer Inst; 1982 Aug; 69(2):357-64. PubMed ID: 6180206
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of complex antigenic heterogeneity in a human glioma cell line and eight derived clones by specific monoclonal antibodies.
Wikstrand CJ; Bigner SH; Bigner DD
Cancer Res; 1983 Jul; 43(7):3327-34. PubMed ID: 6303581
[TBL] [Abstract][Full Text] [Related]
5. Phenotyping of 60 cultured human gliomas and 34 other neuroectodermal tumors by means of monoclonal antibodies against glioma, melanoma and HLA-DR antigens.
de Muralt B; de Tribolet N; Diserens AC; Stavrou D; Mach JP; Carrel S
Eur J Cancer Clin Oncol; 1985 Feb; 21(2):207-16. PubMed ID: 2985398
[TBL] [Abstract][Full Text] [Related]
6. Characterization of three restricted specificity monoclonal antibodies raised against the human glioma cell line D-54 MG.
Wikstrand CJ; Bigner SH; Bigner DD
J Neuroimmunol; 1984 Jun; 6(3):169-86. PubMed ID: 6373821
[TBL] [Abstract][Full Text] [Related]
7. Production and characterization of two human glioma xenograft-localizing monoclonal antibodies.
Wikstrand CJ; McLendon RE; Bullard DE; Fredman P; Svennerholm L; Bigner DD
Cancer Res; 1986 Nov; 46(11):5933-40. PubMed ID: 3756930
[TBL] [Abstract][Full Text] [Related]
8. Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody.
Bourdon MA; Wikstrand CJ; Furthmayr H; Matthews TJ; Bigner DD
Cancer Res; 1983 Jun; 43(6):2796-805. PubMed ID: 6342760
[TBL] [Abstract][Full Text] [Related]
9. Expression of HLA-DR and common acute lymphoblastic leukemia antigens on glioma cells.
Carrel S; De Tribolet N; Gross N
Eur J Immunol; 1982 Apr; 12(4):354-7. PubMed ID: 6954072
[TBL] [Abstract][Full Text] [Related]
10. Surface antigenic characteristics of human glial brain tumor cells.
Wikstrand CJ; Mahaley MS; Bigner DD
Cancer Res; 1977 Dec; 37(12):4267-75. PubMed ID: 72598
[TBL] [Abstract][Full Text] [Related]
11. Reactivity of antiglioma monoclonal antibodies for a large panel of cultured gliomas and other neuroectoderm derived tumors.
de Muralt B; de Tribolet N; Diserens AC; Carrel S; Mach JP
Anticancer Res; 1983; 3(1):1-6. PubMed ID: 6830147
[TBL] [Abstract][Full Text] [Related]
12. Human fetal brain antigen expression common to tumors of neuroectodermal tissue origin.
Wikstrand CJ; Bourdon MA; Pegram CN; Bigner DD
J Neuroimmunol; 1982 Aug; 3(1):43-62. PubMed ID: 6284796
[TBL] [Abstract][Full Text] [Related]
13. Expression of neuroectodermal antigens common to melanomas, gliomas, and neuroblastomas. I. Identification by monoclonal anti-melanoma and anti-glioma antibodies.
Carrel S; de Tribolet N; Mach JP
Acta Neuropathol; 1982; 57(2-3):158-64. PubMed ID: 6181646
[TBL] [Abstract][Full Text] [Related]
14. Morphological heterogeneity and phenotype modifications during long term in vitro cultures of six new human glioblastoma cell lines.
Dipasquale B; Colombatti M; Tridente G
Tumori; 1990 Apr; 76(2):172-8. PubMed ID: 2330609
[TBL] [Abstract][Full Text] [Related]
15. Expression of human fetal brain antigens by human tumors of neuroectodermal origin as defined by monoclonal antibodies.
Wikstrand CJ; Bigner DD
Cancer Res; 1982 Jan; 42(1):267-75. PubMed ID: 6274512
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies reactive with glioma cell lines derived from experimental brain tumors.
Stavrou D; Süss C; Bilzer T; Kummer U; De Tribolet N
Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1439-49. PubMed ID: 6196200
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies in neuro-oncology.
Stavrou D
Neurosurg Rev; 1990; 13(1):7-18. PubMed ID: 2181345
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies to human melanoma associated antigens: study of their specificity and visualization at the cellular level of the antigenic distribution.
Libert A; Ghanem G; Arnould R; Vercammen-Grandjean A; Carrel S; Lejeune F
Anticancer Res; 1983; 3(4):219-25. PubMed ID: 6576727
[TBL] [Abstract][Full Text] [Related]
19. Common antigenic determinants on human melanoma, glioma, neuroblastoma, and sarcoma cells defined with monoclonal antibodies.
Seeger RC; Rosenblatt HM; Imai K; Ferrone S
Cancer Res; 1981 Jul; 41(7):2714-7. PubMed ID: 6166367
[TBL] [Abstract][Full Text] [Related]
20. Reactivity of monoclonal antibodies against human leucocyte antigens with lymphocytes of non-human primate origin.
Neubauer RH; Levy R; Strnad BC; Rabin H
J Immunogenet; 1981 Dec; 8(6):433-42. PubMed ID: 6801142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
